Literature DB >> 1465757

B lymphocyte accumulations in human pulmonary sarcoidosis.

S B Fazel1, S E Howie, A S Krajewski, D Lamb.   

Abstract

BACKGROUND: Although cell mediated immunity is primarily thought to mediate the pathogenesis of sarcoidosis, the presence of immunoglobulins, immune complexes and complement suggests that processes of humoral immunity may contribute to immunopathology in sarcoid lesions. To test this hypothesis, the distribution of B lymphocytes in paraffin embedded sarcoid lesions in mediastinal lymph nodes and open lung biopsy specimens was investigated.
METHODS: Paraffin sections from eight open lung and 21 lymph node biopsies from sarcoid patients and five normal and five tuberculous lymph nodes from patients with tuberculosis were stained with a panel of monoclonal antibodies by means of avidin/biotin enhanced immunocytochemistry.
RESULTS: Immunohistochemical analysis of the 29 biopsy specimens from the sarcoid patients revealed large numbers of B cells in the intergranulomatous regions. Further investigations in the open lung biopsy specimens indicated that these B cells were often organised into discrete circular or oval shaped aggregates with no germinal centre morphology, in which a few CD45RO memory T lymphocytes were scattered. The B cells were polyclonal, and a few plasma cells (IgM+, IgA+, IgG+) were identified.
CONCLUSIONS: The finding of large numbers of B lymphocytes in sarcoid pulmonary lesions is in contrast to bronchoalveolar lavage studies, which have demonstrated proportions of 5% or less of B cells as a total of all immune cells, and therefore indicates that bronchoalveolar lavage may not correctly sample the immune cells of lung interstitial tissue in pulmonary sarcoidosis. The B cells at these sites are the possible origin of some of the humoral changes in the serum and lesions of sarcoid patients. They may also influence the pathogenesis of the disorder by presenting antigen(s) and forming immune complexes at sites of disease activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465757      PMCID: PMC464115          DOI: 10.1136/thx.47.11.964

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  18 in total

1.  Functional significance of anti-T-lymphocyte antibodies in sarcoidosis.

Authors:  J R Spurzem; C Saltini; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1988-03

2.  T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes.

Authors:  Y Ron; J Sprent
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

3.  Study of immune complexes in bronchoalveolar lavage fluids.

Authors:  P P Dall'Aglio; A Pesci; G Bertorelli; E Brianti; S Scarpa
Journal:  Respiration       Date:  1988       Impact factor: 3.580

4.  Immune complexes in sarcoidosis: a correlation with activity and duration of disease.

Authors:  R P Daniele; L J McMillan; J H Dauber; M D Rossman
Journal:  Chest       Date:  1978-09       Impact factor: 9.410

5.  Relation between immunocytological features of bronchoalveolar lavage fluid and clinical indices in sarcoidosis.

Authors:  G M Ainslie; L W Poulter; R M du Bois
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

6.  Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment.

Authors:  J L Ceuppens; L M Lacquet; G Mariën; M Demedts; A van den Eeckhout; E Stevens
Journal:  Am Rev Respir Dis       Date:  1984-04

7.  Cellular composition of hypersensitivity-type granulomas: immunohistochemical analysis of tuberculous and sarcoidal lymphadenitis.

Authors:  J J van den Oprd; C de Wolf-Peeters; F Facchetti; V J Desmet
Journal:  Hum Pathol       Date:  1984-06       Impact factor: 3.466

8.  The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice.

Authors:  E A Kurt-Jones; D Liano; K A HayGlass; B Benacerraf; M S Sy; A K Abbas
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

9.  Immunocompetent cells in bronchoalveolar lavage reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis.

Authors:  D A Campbell; L W Poulter; R M du Bois
Journal:  Am Rev Respir Dis       Date:  1985-12

10.  Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations.

Authors:  G Semenzato; C Agostini; R Zambello; L Trentin; M Chilosi; M R Angi; E Ossi; A Cipriani; G Pizzolo
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

View more
  18 in total

1.  Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Shaw M Akula; George Sigounas; Yash P Kataria; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

2.  Cellular immune suppressor activity resides in lymphocyte cell clusters adjacent to granulomata in human coccidioidomycosis.

Authors:  Lijin Li; Sharon M Dial; Monika Schmelz; Margaret A Rennels; Neil M Ampel
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 3.  Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?

Authors:  Lindsay J Celada; Wonder P Drake
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

Review 4.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

5.  Autoantibody profile in sarcoidosis, analysis from the GRADS sarcoidosis cohort.

Authors:  Basheer Khassawneh; Chengsong Zhu; Briana Barkes; Brian Vestal; Sarah Shrock; May Gillespie; Karin Pacheco; Kevin D Deane; Lisa A Maier; Quan-Zhen Li; Nabeel Hamzeh
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 6.  Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.

Authors:  Amy S McKee; Shaikh M Atif; Michael T Falta; Andrew P Fontenot
Journal:  J Immunol       Date:  2022-04-15       Impact factor: 5.426

7.  Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.

Authors:  W A Wallace; S N Roberts; H Caldwell; E Thornton; A P Greening; D Lamb; S E Howie
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

8.  Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis.

Authors:  Masaru Ando; Akihiko Goto; Yukiko Takeno; Mari Yamasue; Kosaku Komiya; Kenji Umeki; Shin-Ichi Nureki; Eishi Miyazaki; Jun-Ichi Kadota
Journal:  Clin Rheumatol       Date:  2018-06-23       Impact factor: 2.980

9.  Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels.

Authors:  Anne Saussine; Abdellatif Tazi; Séverine Feuillet; Michel Rybojad; Caroline Juillard; Anne Bergeron; Valérie Dessirier; Fatiha Bouhidel; Anne Janin; Armand Bensussan; Martine Bagot; Jean-David Bouaziz
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

10.  Serum B cell activating factor (BAFF) and sarcoidosis activity.

Authors:  Kamila Hashemzadeh; Maryam Fatemipour; Seyede Zahra Mirfeizi; Mohammadhasan Jokar; Zhaleh Shariati Sarabi; Mohammad-Reza Hatef Fard; Houshang Rafatpanah; Mandana Khodashahi
Journal:  Arch Rheumatol       Date:  2020-09-11       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.